Literature DB >> 34251110

[Long-term results of radical surgery treatment of patients with bladder cancer].

B K Komyakov1,2, A V Sergeev1,2, V A Fadeev1,2, T H Al-Attar1,2, E O Stetsik1,2, A Y Ulyanov1,2, Y S Savashinsky1,2, Kirichenko A O1,2, L M Rodygin1,2.   

Abstract

PURPOSE: To investigate long-term results after radical cystectomy in patients with bladder cancer.
MATERIALS AND METHODS: Since 1997 to 2020 yy. we have performed 404 radical cystectomy with different methods of derivation for patients with bladder cancer in our clinic. There were 342 (86,4%) men and 62 (13,6%) women. Laboratory study, ultrasound, X-ray, CT. MRI investigations were performed in all patients.
RESULTS: Mortality rate was 2,9%. Early and late postoperative complications have occurred in 136 (33,6%) and 98 (41,8%) cases, respectively. Local recurrence has occurred in 33 (8,5%) patients. 10-years overall and cancer-specific survival were 43,4% and 47,2%, respectively. In lymph-negative patients 2-years and 5-years overall survival were 81,2% and 67,2%, respectively. In lymph positive patients 2-years and 5-years overall survival were 46,9% and 13,9%, respectively. In lymph-negative patients 2-years and 5-years cancer-specific survival were 83,6% and 70,7%, respectively. In lymph positive patients 2-years and 5-years cancer-specific survival were 51,0% and 15,1%, respectively. Overall and cancer -specific survival decreased according to increasing pT-stage and histopathologic grade.
CONCLUSIONS: pT-stage (pT), lymp nodes status (pN), histopathologic grade ( pG) have a significant independent influence on overall and cancer-specific survival of bladder cancer patients after radical cystectomy.

Entities:  

Keywords:  bladder cancer; radical cystectomy; survival; urine derivation

Mesh:

Year:  2021        PMID: 34251110

Source DB:  PubMed          Journal:  Urologiia        ISSN: 1728-2985


  1 in total

1.  Preoperative Nutritional Risk Assessment for Predicting Complications after Radical Cystectomy plus Urinary Diversion for Bladder Cancer.

Authors:  Xing Wei; Jia Wang; Haitao Liu; Weizhe Fan; Gang Guo
Journal:  Emerg Med Int       Date:  2022-08-16       Impact factor: 1.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.